$FITX .0048 NewsCreative Edge Nutrition, Inc. Secures

New Post Public Reply Private Reply Replies (0) Message Board
jstops

[b]$FITX[/b] .0048 NewsCreative Edge Nutrition, Inc. Secures $2.0 Million Financing Contract

MADISON HEIGHTS, Mich., Dec. 12, 2012 /PRNewswire via COMTEX/ -- Creative Edge Nutrition, Inc. (PINKSHEETS: FITX), a nutritional supplement company focusing on active lifestyles, announces its financing contract with Ashford Finance LLC based in New York, NY. Under the terms of the contract, Ashford Finance will provide an initial revolving Line of Credit of $2 million dollars in purchase order financing, and provide additional financing for accounts receivable and transactional working capital. The Lines of Credit will allow Creative Edge to immediately increase its efficiency in processing purchase orders from its qualified distributors. Creative Edge has secured initial purchase orders for its Cenergy and SDN brand products in excess of $780,000 USD, with additional purchase order pipeline of $2.4 million dollars, from its approved distributors. Ashford Finance has approved the initial purchase orders, and is able to provide scalable financing to meet Creative Edge needs, which will strategically position the Company for rapid expanded distribution and exponential growth.

Bill Chaaban, CEO, states, "Ashford Finance is an international finance company that will underwrite our qualified distributors in the U.S. and Canada, and will work with some of the larger distributors in Australia and Europe. They are a seasoned finance company, and have the ability to increase our Lines Of Credit based on volume orders, which will equip us for rapid penetration and exponential growth, through our distribution network of over thirty companies. Additionally, Ashford will assist us in inspection services and invoicing, with its great reputation with industry manufacturers and distributors. We look forward to a mutually rewarding and profitable financing partnership."

Noushir Hasan, Ashford Finance CEO, states, "Ashford Finance brings a global team and partners that deliver excellence and professionalism, and we will work with Creative Edge Nutrition, Inc. to take care of all their purchase order financing needs, from their smaller approved buyers, to a few of the industry's largest nationwide retailers. They present great products in a growing nutritional supplement marketplace, and we will provide scalable financing options to service to their distributors and customers."

About Ashford Finance www.ashfordfinance.com Ashford Finance is a specialized finance company based in New York, providing purchase order financing, letters of credit and creative short-term transactional financing for importers, exporters, and other short-term borrowers. Ashford provides 100% funding of cost, and also overlays an operational management process that ensures the goods are of proper quality, insured, and shipped on time. Ashford Finance has over 17 years of experience, managed by professionals with extensive trade, finance and merchant banking backgrounds.

About Creative Edge Nutrition, Inc. Creative Edge Nutrition is a holding company and a Nutritional Supplement Company focused on developing innovative, high quality supplements. The company offers a broad spectrum of capsules, tablets, and powders, as well as science based products in the principal categories of weight management, nutrition challenges, energy and fitness. The Company manufactures under strict GMP guidelines at GMP Certified and/or FDA registered facilities. www.CenergyNutrition.com and http://www.facebook.com/pages/Creative-Edge-N...4738609211

Our websiteswww.chesapeakenutraceuticals.com www.supplementstogo.comwww.a-z-nutrition.com www.sciencedefinednutrition.comwww.worldclassnutrition.com www.fulfillmentinnovation.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 597

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 385

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 179

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 107

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 311

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 245

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 296

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 200

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 477

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 0

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

Midi Health and Mount Sinai Team Up for Menopause Care Access

Updated Category News Views 111

Midi Health and Mount Sinai Health System Join Forces Midi Health is excited to announce a new collaboration with Mount Sinai Health System, aimed at improving access to specialized menopause care for women in the New York City area. This partnership represents a crucial step in addressing the unmet needs of women experiencing perimenopausal and menopausal challenges. Why...

Continue Reading
Surety One, Inc.'s Charitable Matching Program Empowers Employees

Updated Category News Views 191

Surety One, Inc. Launches Charitable Matching Initiative Surety One, Inc. recently announced a noteworthy initiative: a corporate charitable matching program aimed at amplifying employee generosity. Through this program, the company will match employee donations to approved nonprofit organizations, offering a dollar-for-dollar match up to $2,500 per employee annually....

Continue Reading
Exploring Microsoft Stock's Seasonal Performance Before Earnings

Updated Category News Views 307

Could Now Be the Right Time to Invest in Microsoft? As Microsoft Corp. (NASDAQ: MSFT) prepares to unveil its fiscal first-quarter earnings soon, the question on the minds of many investors is whether now is an opportune moment to dive into this tech giant's stock. Data suggests a compelling case for this. Microsoft's Persuasive Seasonal Patterns Historically, the period...

Continue Reading
Foresight Technology VCT Reinforces Market Presence Through Buyback

Updated Category News Views 118

Strategic Share Buyback by Foresight Technology VCT PLC FORESIGHT TECHNOLOGY VCT PLC LEI: 21380013CXOR8N6OD977 The Board of Foresight Technology VCT plc has embarked on a strategic move to enhance its market dynamics. Recently, the Company executed a buyback, acquiring 35,274 of its FWT shares at a gross price of 87.88p each. This transaction occurred on the 24th of...

Continue Reading
Quarterhill's Virtual Annual Meeting Highlights Upcoming Changes

Updated Category News Views 157

Quarterhill's Virtual Annual Meeting Details Quarterhill Inc. is gearing up for its Annual and Special Meeting of shareholders, which will take place virtually. This exciting opportunity allows registered shareholders and proxyholders to participate actively by asking questions and voting in real time. They must follow the instructions mentioned in Quarterhill's...

Continue Reading